(Q28168748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Fran Balkwill

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Adrian Harris

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

4

P Thavasu

1 reference

28 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

K Christodoulos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

N Dobbs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

A D Blann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

G J Caine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

S Kumar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

A J Kakkar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

N Gompertz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

D C Talbot

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

T S Ganesan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

30-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

28 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Prevention of venous thromboembolism in cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Long-term experience with captopril in severe hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Angiogenesis: initiation and modulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

2 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601897

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601897

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601897

Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601897

Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364746

Processing of tumour necrosis factor-α precursor by metalloproteinases

27 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601897

Interaction of heparin with human angiogenin

21 January 2018

1 reference

12 December 2020

The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production

1 reference

12 December 2020

Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions

1 reference

12 December 2020

Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma

1 reference

12 December 2020

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

12 December 2020

The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients

1 reference

12 December 2020

Measuring cytokine levels in blood

1 reference

12 December 2020

The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease

1 reference

12 December 2020

Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15162145%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

15162145

1 reference